Successful Treatment of a Monoamine Oxidase Inhibitor–Tyramine Hypertensive Emergency with Intravenous Labetalol
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tranylcypromine is the most likely of the monoamine oxidase inhibitors to raise blood pressure compared with moclobemide and brofaromine.
“Tranylcypromine is the most likely of the agents to raise BP compared with moclobemide and brofaromine.244,245”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [244]
Cites
Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptors
Farmer, J. B., Kennedy, I., Levy, G., et al. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb08125.x · Cited by 212 · see citing works
Interactions of Monoamine Oxidase Inhibitors, Amines, and Foodstuffs
Marley, E., & Blackwell, B. (1971) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60597-9 · Cited by 94 · see citing works
Intravenous labetalol in the management of severe hypertension and hypertensive emergencies
Cressman, M. D., Vidt, D. G., Gifford, R. W., et al. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90838-x · Cited by 62 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153 · see citing works
- Authors
- Hubbard, J. D., Inkeles, S. B., & Barnard, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1985-07-04
- Volume
- 313
- Issue
- 1
- Pages
- 52-52
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2418574599
- Cited by
- 15
- References
- 3
- Citations by year
- 2025: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2014: 2
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- monoamine oxidase inhibitors, tyramine, hypertensive emergency, labetalol, drug interactions, intravenous antihypertensive therapy, adverse drug reactions
- MeSH terms
- Aged, Coronary Disease, Diet, Dietary Fats, Famous Persons, Humans, Male, Myocardium, United States, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
